Aquaporin (AQP) Q3 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 TU earnings summary
13 Jun, 2025Financial performance and guidance
Revenue for Jan–Sep 2024 reached DKK 32.8 million, up from DKK 31.3 million in 2023, but Q3 revenue dropped to DKK 3.6 million due to lower orders and project delays.
Industrial Water revenue in Q3 rose to DKK 2.1 million from DKK 0.5 million in 2023.
EBIT loss improved to DKK 20.3 million in Q3 2024 from DKK 25.1 million in Q3 2023.
Cash and cash equivalents stood at DKK 93.1 million after a DKK 172.4 million rights issue in April 2024.
Full-year 2024 guidance maintained: revenue DKK 40–45 million, gross profit margin 30–35%, EBIT loss DKK 90 million.
Business and operational highlights
Entered a strategic distribution partnership with Brenntag for APAC and Turkey, expanding industrial reach.
Launched the CLEAR Series in China, targeting energy savings in water treatment for various sectors.
Achieved milestones in a joint development project with E. & J. Gallo Winery for innovative FO solutions.
Opened a new polymer lab to advance next-generation Aquaporin Inside® protein technology.
Subsequent and strategic events
Secured the largest order to date for CLEAR elements for a municipal project in Central Asia.
Expanded Brenntag partnership in China with a Letter of Intent at the China International Import Expo.
Aquaporin Space Alliance signed a new contract with ESA for a space water recovery system.
Laboratory advancements indicate potential for increased energy efficiency with Next Generation Aquaporin Inside® technology.
Latest events from Aquaporin
- 44% revenue growth, improved margins, and 2024 outlook reaffirmed after capital raise.AQP
H1 202423 Jan 2026 - 2024 revenue fell 32% but Industrial Water surged 192%; rights issue and incentives below target.AQP
H2 202423 Dec 2025 - Revenue guidance cut after sharp H1 decline, with strategic review to secure future funding.AQP
H1 202523 Nov 2025 - Q3 revenue rose 14% year-on-year as capital-raising efforts intensify for future growth.AQP
Q3 2025 TU13 Nov 2025 - Q1 revenue declined but guidance held as orderbook and strategic growth support 2025 outlook.AQP
Q1 2025 TU6 Jun 2025